Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients. - Wikidata - awgldk - TriplyDB

Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients.

Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients.

http://www.wikidata.org/entity/Q34769934

about

EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line PIN3 duplication may be partially responsible for TP53 haploinsufficiency Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients.Using the molecular classification of glioblastoma to inform personalized treatment.Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.The failure in the stabilization of glioblastoma-derived cell lines: spontaneous in vitro senescence as the main culprit.Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis.Astrocytoma-associated antigens - IL13Rα2, Fra-1, and EphA2 as potential markers to monitor the status of tumour-derived cell cultures in vitro.Functional network analysis of gene-phenotype connectivity associated with temozolomide.

P2860

Q28551853-6ED47E43-716A-4C96-8778-F40EA44FDB56 Q34252210-8C4D1257-BF7E-40DE-94EE-74CE452296EA Q37665244-895D6073-878F-45C6-A0B1-3347610B528A Q38151582-CAC3F722-234B-4ED2-A062-7AEBCA351C98 Q38223605-18CB4F6B-B3DB-4943-B95B-999679CCB8FD Q39027058-C8F6A6E2-95A3-42EB-BFF6-C1FFAF0D4F3D Q41110170-2A18B499-8234-4114-AE5F-437FB9F0C976 Q41194722-F15C72FE-4D56-4AE1-9E8C-0A1A0B1B38E7 Q47258480-9CCFA855-5468-4E42-B8F6-CBDACCFCE011

P2860

Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients.

http://www.wikidata.org/entity/Q34769934

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Screening for EGFR amplificati ...... come of glioblastoma patients.

@ast

Screening for EGFR amplificati ...... come of glioblastoma patients.

@en

Screening for EGFR amplificati ...... come of glioblastoma patients.

@nl

type

label

Screening for EGFR amplificati ...... come of glioblastoma patients.

@ast

Screening for EGFR amplificati ...... come of glioblastoma patients.

@en

Screening for EGFR amplificati ...... come of glioblastoma patients.

@nl

prefLabel

Screening for EGFR amplificati ...... come of glioblastoma patients.

@ast

Screening for EGFR amplificati ...... come of glioblastoma patients.

@en

Screening for EGFR amplificati ...... come of glioblastoma patients.

@nl

P1433

Q34769934-F9E62567-21B8-4F4F-B737-1E8F87013FB6

P1476

Q34769934-A2383CA5-EA05-4AA0-975C-A2D690B74871

P2093

Q34769934-1133E400-7FC8-427E-9825-9B82B3D69C9A

Q34769934-19C1CF67-3D39-46BC-B4F9-CBCBCB911946

Q34769934-1B7D13AF-4282-4DC9-93F8-385289E298D1

Q34769934-35119E52-F84C-4A52-86F3-373EF0C614C7

Q34769934-48AFB37F-6505-41B1-AA87-8D90D7D3BA12

Q34769934-5CA03369-911D-46A8-8517-511B79FB60B5

Q34769934-7895A412-C744-4C89-96C5-5557BA320FA7

Q34769934-7D076A73-1EE6-491D-8919-A5F9880C6EF9

Q34769934-8E62F62E-343D-4042-BDD4-08CD794CE5B0

Q34769934-A04381A7-925E-430F-AA7C-44E906949606

P2860

Q34769934-0DC6AB3E-ABEF-4BB9-8C7B-9D94A180B4A2

Q34769934-11627060-8762-4A9E-AC7D-FB0A4287C123

Q34769934-18B439E7-8E2C-4951-A8F0-CCB6887ADD42

Q34769934-22F645F3-686E-47EA-9958-6717C3E8247F

Q34769934-29574B06-CFC8-4A6D-955F-CF729B683572

Q34769934-2C791C09-A884-40DE-BE40-49DA6E420513

Q34769934-321B2954-887C-4E8A-9C1A-F328BDBC8887

Q34769934-33185373-491C-4A25-98CF-364E8C96A10D

Q34769934-40B5F6A1-1883-496B-920B-53E61CB15693

Q34769934-41B06B2B-62D1-4976-9448-2E4C35EBFD61

P304

Q34769934-6778F2EB-3508-4045-9DEA-689A5626F933

P31

Q34769934-D3513FDF-9E38-4B3C-B976-BFE0B8434C88

P356

Q34769934-5A41E4CB-03A1-4F05-A099-56DE37911B47

P407

Q34769934-D9B0C3EB-A1BF-4A44-8FA6-39D8A0DDD07E

P433

Q34769934-DC728155-0C7E-4426-8CFD-A8A85A87D7F5

P478

Q34769934-14A3A5B9-15EE-4B6E-82DC-3B834250F12A

P577

Q34769934-D8CBB7DA-090C-4DDF-87D0-D0D275304D68

P5875

Q34769934-71B838C9-4806-434A-96A6-A6C0554EE26A

P698

Q34769934-B38AED61-0E14-4E57-B156-4C7862623D27

P932

Q34769934-BEDEAB05-05B2-4555-B70B-D351E91F579D

P356

JOURNAL.PONE.0065444

P1433

P1476

Screening for EGFR amplificati ...... come of glioblastoma patients.

@en

P2093

Anna Radomiak-Załuska

http://www.w3.org/2001/XMLSchema#string

Beata Sikorska

http://www.w3.org/2001/XMLSchema#string

Dariusz J Jaskólski

http://www.w3.org/2001/XMLSchema#string

Dorota Jesionek-Kupnicka

http://www.w3.org/2001/XMLSchema#string

Emilia Jesień-Lewandowicz

http://www.w3.org/2001/XMLSchema#string

Ewelina Stoczyńska-Fidelus

http://www.w3.org/2001/XMLSchema#string

Mateusz Banaszczyk

http://www.w3.org/2001/XMLSchema#string

Małgorzata Szybka

http://www.w3.org/2001/XMLSchema#string

Michał Bieńkowski

http://www.w3.org/2001/XMLSchema#string

Monika Witusik-Perkowska

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

The natural history of EGFR and EGFRvIII in glioblastoma patients

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.

Determining frequent patterns of copy number alterations in cancer.

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.

P304

e65444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0065444

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237839897

http://www.w3.org/2001/XMLSchema#string

P698

23762372

http://www.w3.org/2001/XMLSchema#string

P932

3675194

http://www.w3.org/2001/XMLSchema#string